NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
AI’s Growing Role in Assessing Oocyte Quality Assessment – RBMO
RBMO/LinkedIn
Mar 20, 2026, 15:57

AI’s Growing Role in Assessing Oocyte Quality Assessment – RBMO

Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:

“Significant advances have been made with regards to quantifying the viability of the preimplantation stage human embryo, through the analysis of morphokinetics, quantification of biomarkers, and trophectoderm biopsy to facilitate PGT. However, we still have limited capacity to determine the inherent potential of gametes.

In this new Commentary, David Gardner, Helen O’Neill, Basak Balaban, Marcos Meseguer Escrivá, Thomas Freour, and Laura Rienzi discuss the developments in AI, media analysis and microscopies to assess metabolic state, which could provide valuable insights into oocyte health, thereby increasing our ability to not only improve oocyte health and selection but also provide a much-needed tool to assist in optimising ovarian stimulation.

All our Commentaries are made free to read – find it in our April issue, ahead of publication, now.”

Title: Oocyte quality in the era of AI: integration of morphology, metabolic activity and time-lapse imaging

Authors: David K Gardner, Helen C O’Neill, Başak Balaban, Marcos Meseguer, Thomas Freour, Laura Rienzi

Oocyte

Stay updated on all scientific advances in the field of fertility with Fertility News.

analysis of morphokinetics BASAK BALABAN David Gardner David K. Gardner Fertility Fertility News Helen C O’Neill Helen O’Neill Human Embryo Laura Rienzi Marcos Meseguer Marcos Meseguer Escrivá metabolic state Oocyte Health ovarian stimulation PGT quantification of biomarkers RBMO Reproductive BioMedicine Online reproductive health Reproductive Medicine Thomas Freour Trophectoderm Biopsy
NewsFeed